RESUMEN
This study analyzed the selective attention processing related to cognitive load on simultaneous interpretation (SI). We tested simultaneous interpreter's brain function using EEG signals and calculated inter-trial coherence (ITC) extracted by the 40-Hz auditory steady-state response (ASSR). In this experiment, we set two conditions as Japanese-English translation and Japanese shadowing cognition. We also compared two subject groups: S rank with more than 15 years of SI experience (n=7) and C rank with less than one year experience (n=15). As a result, the ITCs for S rank in interpreting conditions were more significantly increased than C rank in the shadowing conditions (ITC: p<0.001). Our results demonstrate that 40-Hz ASSR might be a good indicator of selective attention and cognitive load during SI in ecologically valid environmental conditions. It can also be used to detect attention and cognitive control dysfunction in ADHD or schizophrenia.
Asunto(s)
Electroencefalografía , Potenciales Evocados Auditivos , Estimulación Acústica , Atención , Sincronización de Fase en ElectroencefalografíaRESUMEN
BACKGROUND: Carbapenem-resistant Enterobacteriaceae (CRE), especially for carbapenemase-producing Enterobacteriaceae (CPE), is an emerging cause that pose a significant threat to public health. However, efficient therapy has not been established. We assessed the antimicrobial efficacy of meropenem (MEPM) and amikacin (AMK) combination therapy. MATERIAL AND METHODS: Total eight isolates of Escherichia coli or Klebsiella pneumoniae, including CRE and/or CPE have carbapenemase genes were used. The relationship between phenotype and in vivo efficacy was assessed in neutropenic murine thigh infection model. Efficacy was determined using the change in bacterial density and survival rate. RESULTS: The combination therapy showed enhanced antimicrobial activities against CRE+/CPE+ and CRE+/CPE-K. pneumoniae isolates than MEPM monotherapy (0.63 ± 0.04 vs. 2.56 ± 0.24 â¿log10 cfu/mL, p < 0.05; -1.05 ± 0.15 vs. -0.48 ± 0.30 â¿log10 cfu/mL, p < 0.05). Likewise, the combination therapy showed enhanced antimicrobial activities against CRE+/CPE+ and CRE+/CPE-E. coli isolates than MEPM monotherapy (0.90 ± 0.68 vs. 1.86 ± 0.23 â¿log10 cfu/mL, p < 0.05; -1.81 ± 0.06 vs. -0.88 ± 0.23 â¿log10 cfu/mL, p < 0.05). Also, combination therapy group showed similar to higher survival rates in CRE + E. coli infection mice, compared to MEPM monotherapy group. CONCLUSION: Our results are the first supportive data to threat CRE infections with combination therapy of MEPM and AMK with in vivo model. The current results verify the promising utility of the combination therapy with MEPM and AMK against CRE isolates with a wide range of MEPM MICs.